Emerging Innovation

Three Trends for Growth Stock Investors

23 7月 2021
4 Minute Read
Emerging market (EM) countries have long relied on commodity cycles and low-cost manufacturing for export-driven growth. But a wave of corporate innovation is changing that, helping to drive growth from within and providing equity investors with higher quality, sustainable opportunities across many countries.
 
Investors in EM stocks are facing challenges with countries like India and Brazil still struggling to contain COVID-19. The MSCI Emerging Markets Index rose by 6.5% this year through June 30 in US-dollar terms, trailing the MSCI World Index’s 12.2%. Growth stock returns were weaker. But as the earnings outlook improves, we believe that three powerful long-term trends, driven by innovation, are creating growth opportunities that will persist through the pandemic and beyond.

Trend 1: New Technology for Emerging Economies

Technology is leading the charge. Today, technology and internet-centric companies make up 40% of the EM benchmark, up from only 11% in December 2007. In comparison, tech stocks comprise 39% of the MSCI USA Index and only 9% of the MSCI Europe Index. We think the extraordinary growth story of emerging market tech is only beginning.

This new wave of EM technology isn't only about exports. Indeed, many EM companies are developing new technologies for use at home. In many cases, these companies have advantages in capturing local market share versus US peers, and it’s not just happening in China. Local internet companies are growing fast and establishing strong market positions in countries as diverse as India, South Korea or Russia.

The breakthroughs go well beyond shopping. What is one of the fastest-growing markets for financial technology? India. In 2020, India processed US$25.5 billion in real-time payments, according to ACI Worldwide. Banks in India are leveraging technology and big data to grow their business. 

Trend 2: The Pandemic Changed Healthcare in Unexpected Ways

Some recent emerging market advances were products of the pandemic. The lockdowns caused both EM companies and consumers to move everything from shopping to business meetings online, much like in developed economies.

Chinese healthcare also underwent a pandemic-accelerated transformation in 2020. Innovations were swiftly adopted and created a path for future growth.

China had banned online pharmacies before 2019, so they were still in their infancy when the pandemic began. In a swift about-face, China started actively promoting online drug sales in 2020 to alleviate bottlenecks. It's now a US$53 billion industry and is expected to exceed US$300 billion by 2030.

Online health consultations were also quickly normalized. In the first quarter of 2020, online doctor appointments in China increased 17 times over the same period in 2019. The pandemic highlighted the benefits and efficiencies of online healthcare. Remote diagnosis, for example, helps solve healthcare issues for rural populations, allowing centrally located doctors to treat patients thousands of miles away.

Online systems lower costs and can better monitor chronic conditions, leading to better health. And artificial intelligence now supports clinical decision-making, also improving efficiency. Beyond China, countries with aging demographics and surging healthcare needs provide a ready market for these technological advancements. Companies in China that have facilitated these trends are well positioned to foster broader proliferation of post-pandemic healthcare innovation.

Trend 3: Green Technology for Home and Abroad

Over 200 countries now support the Paris Agreement, and governments worldwide are adopting policies to curb global warming. We expect over US$2 trillion in low-carbon initiative spending just in emerging-market countries over the next 20 years. Companies creating cutting-edge environmental solutions can sell into governments who have pledged to do better environmentally.

State-of-the-art battery technology destined for electric vehicles, for example, is coming from South Korea and China. Today, around 30% of the cost of an electric car is the battery. But rapid technological advances are improving economics and demand, and battery costs are dropping almost 10% per year. Electric cars could cost the same as those with internal combustion engines within two to three years. As many countries seek to ban internal combustion engines in as little as five to ten years, that's welcome news.

Another growth market stemming from the environmental movement is the treatment of industrial and medical waste. Demand for these services is naturally increasing, and stricter regulations are an added tailwind. New waste disposal facilities are coming online, but capacity constraints remain, and there are high barriers to entry. And as emerging economies grow, there are opportunities for remediating previous environmental damage, as regulations have generally lagged industrialization. 

EM Valuations Are Compelling

While developed market companies are strong players in some of these markets, EM competitors provide compelling benefits for investors. Many EM stocks offer higher quality, more sustainable growth and are often available at less expensive valuations than developed market peers. Even though analysts expect higher earnings growth in 2021, EM stocks currently trade at an almost 30% discount to developed market peers (Display).

EM Stocks: Stronger Earnings Prospects, Cheaper Valuations
MSCI EM earnings are growing 48% versus 36% for MSCI World, but EM trades at a 30% discount.

Past performance and historical analysis does not guarantee future results.
In US dollars
*Based on consensus earnings per share estimates
As of May 31, 2021

Subdued sentiment in key emerging markets is clouding exciting growth trends. While the short-term outlook is challenging, it’s actually a great time to shop for stocks that should benefit from longer-term developments. When the forces of the pandemic give way to a sustainable recovery, we believe EM companies with an innovative edge will enjoy disproportionate benefits from pent-up return potential. 

The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams and are subject to revision over time.

MSCI makes no express or implied warranties or representations, and shall have no liability whatsoever with respect to any MSCI data contained herein.
The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed or produced by MSCI.

Investment involves risk. The information contained here reflects the views of AllianceBernstein L.P. or its affiliates and sources it believes are reliable as of the date of this publication. AllianceBernstein L.P. makes no representations or warranties concerning the accuracy of any data. There is no guarantee that any projection, forecast or opinion in this material will be realized. Past performance does not guarantee future results. The views expressed here may change at any time after the date of this publication. This article is for informational purposes only and does not constitute investment advice. AllianceBernstein L.P. does not provide tax, legal or accounting advice. It does not take an investor's personal investment objectives or financial situation into account; investors should discuss their individual circumstances with appropriate professionals before making any decisions. This information should not be construed as sales or marketing material or an offer of solicitation for the purchase or sale of, any financial instrument, product or service sponsored by AllianceBernstein or its affiliates. This presentation is issued by AllianceBernstein Hong Kong Limited (聯博香港有限公司) and has not been reviewed by the Securities and Futures Commission


About the Authors